Search research articles
Contact Us
Filters
Showing results (1-10 of 136) with videos related to
Page
of 14
Sort By:
JAMA
|
April 19, 2022
Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases
Niels Vande Casteele
Frontline Gastroenterology
|
October 26, 2017
Assays for measurement of TNF antagonists in practice
Niels Vande Casteele
Pharmaceutical Research
|
April 5, 2017
Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis
Niels Vande Casteele, Reena Khanna
Inflammatory Bowel Diseases
|
September 27, 2018
Use of Precision Medicine in Clinical Trials in Inflammatory Bowel Disease
Reena Khanna, Niels Vande Casteele
Journal of Crohn'S & Colitis
|
September 10, 2015
High Anti-Tumour Necrosis Factor Trough Concentrations--Only a Cost Issue or Also Hidden Dangers Ahead?
Niels Vande Casteele, Séverine Vermeire
Journal of Clinical Pharmacology
|
February 25, 2015
Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice
Niels Vande Casteele, Ann Gils
Clinical Pharmacokinetics
|
January 14, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
Amy Hemperly, Niels Vande Casteele
Digestive Diseases and Sciences
|
April 29, 2015
Preemptive Dose Optimization Using Therapeutic Drug Monitoring for Biologic Therapy of Crohn's Disease: Avoiding Failure While Lowering Costs?
Niels Vande Casteele, Ann Gils
Alimentary Pharmacology & Therapeutics
|
June 12, 2019
Editorial: assessing histological disease activity in Crohn's disease-a call for standardisation of mucosal biopsy location. Authors' reply
Niels Vande Casteele, Vipul Jairath
The Journal of Pediatrics
|
February 4, 2018
Putting Out the Fire in Acute Kawasaki Disease
Jane C Burns, Niels Vande Casteele
Page
of 14
Search research articles
Search
Showing results (1-10 of 136) with videos related to
Sort By:
Page
of 14
JAMA
|
April 19, 2022
Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases
Niels Vande Casteele
Frontline Gastroenterology
|
October 26, 2017
Assays for measurement of TNF antagonists in practice
Niels Vande Casteele
Pharmaceutical Research
|
April 5, 2017
Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis
Niels Vande Casteele, Reena Khanna
Inflammatory Bowel Diseases
|
September 27, 2018
Use of Precision Medicine in Clinical Trials in Inflammatory Bowel Disease
Reena Khanna, Niels Vande Casteele
Journal of Crohn'S & Colitis
|
September 10, 2015
High Anti-Tumour Necrosis Factor Trough Concentrations--Only a Cost Issue or Also Hidden Dangers Ahead?
Niels Vande Casteele, Séverine Vermeire
Journal of Clinical Pharmacology
|
February 25, 2015
Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice
Niels Vande Casteele, Ann Gils
Clinical Pharmacokinetics
|
January 14, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
Amy Hemperly, Niels Vande Casteele
Digestive Diseases and Sciences
|
April 29, 2015
Preemptive Dose Optimization Using Therapeutic Drug Monitoring for Biologic Therapy of Crohn's Disease: Avoiding Failure While Lowering Costs?
Niels Vande Casteele, Ann Gils
Alimentary Pharmacology & Therapeutics
|
June 12, 2019
Editorial: assessing histological disease activity in Crohn's disease-a call for standardisation of mucosal biopsy location. Authors' reply
Niels Vande Casteele, Vipul Jairath
The Journal of Pediatrics
|
February 4, 2018
Putting Out the Fire in Acute Kawasaki Disease
Jane C Burns, Niels Vande Casteele
Page
of 14